N = 186 | No delirium N = 93 | Delirium N = 93 | ||
---|---|---|---|---|
Age, yr, median [IQR] | 70 [61–80, 8] | 70 [61–80] | 71 [60–81] | |
Sex | Male, n (%) | 114 (61.3%) | 56 (60.2%) | 58 (62.4%) |
Female, n (%) | 72 (38.7%) | 37 (39.8%) | 35 (37.6%) | |
Main diagnosis on admission, n (%) | Acute respiratory failure | 44 (23.7%) | 22 (23.7%) | 22 (23.7%) |
Postoperative | 50 (26.9%) | 25 (26.9%) | 25 (26.9%) | |
Sepsis | 38 (20.4%) | 19 (20.4%) | 19 (20.4%) | |
Acute cardiac disease (*) | 20 (10.8%) | 10 (10.8%) | 10 (10.8%) | |
Coma | 18 (9.7%) | 9 (9.7%) | 9 (9.7%) | |
Cardiac arrest | 8 (4.3%) | 4 (4.3%) | 4 (4.3%) | |
Shock other than sepsis | 8 (4.3%) | 4 (4.3%) | 4 (4.3%) | |
Comorbidities, n (%) | Cardiovascular | 120 (64.5%) | 61 (65.6%) | 59 (63.4%) |
Respiratory | 57 (30.6%) | 30 (32.3%) | 27 (29.0%) | |
Renal | 28 (15.1%) | 11 (11.8%) | 17 (18.3%) | |
Hepatic | 29 (15.6%) | 14 (15.1%) | 15 (16.1%) | |
Cancer disease | 66 (35.5%) | 40 (43.0%) | 26 (28.0%) | |
Endocrine | 84 (45.2%) | 39 (41.9%) | 45 (48.4%) | |
SAPS-3, median [IQR] | 57.5 [4–66] | 56 [48–64] | 59 [49–66] | |
Number of organ failure/s, median (IQR) | 2 [1–3] | 2 [0–2] | 3 [2–4] | |
Organ-supportive treatments | Invasive MV, n (%) | 88 (47.3%) | 30 (32.3%) | 58 (62.4%) |
Days under invasive MV, days (IQR) | 4 [2–10] | 2 [1–5] | 6.5 [3–15] | |
Reintubation, n (%) | 7 (3.8%) | 2 (2.2%) | 5 (5.4%) | |
Non-invasive MV, n (%) | 24 (12.9%) | 14 (15.1%) | 10 (10.8%) | |
CRRT, n (%) | 8 (4.3%) | 3 (3.2%) | 5 (5.4%) | |
LOS ICU, days, median (IQR) | 4 [2–9] | 3 [2–5] | 7 [3–15] | |
LOS hospital after ICU discharge, days, median (IQR) | 8 [4–16] | 8 [4–15] | 10 [5–18] | |
Unplanned readmission to ICU, n (%) | 8 (4.3%) | 1 (1.1%) | 7 (7.5%) | |
Telephone survey response | No, n (%) | 30 (16.1%) | 8 (8.6%) | 22 (23.7%) |
Yes, n (%) | 156 (83.9%) | 85 (91.4%) | 71 (76.3%) | |
Telephone survey recipient | Patient, n (%) | 146 (93.6%) | 81 (95.3%) | 65 (91.5%) |
Surrogate, n (%) | 10 (6,4%) | 4 (4.7%) | 6 (8.5%) |